Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,137 | 60,081 | 127,677 | 59,248 | 100,854 |
| Marketable Securities | 231,428 | 215,765 | 205,611 | 235,607 | 71,938 |
| Receivables | 18,512 | 14,867 | 6,224 | 1,025 | N/A |
| Inventories | 18,741 | 8,624 | 2,917 | 111 | N/A |
| TOTAL | $374,200 | $308,268 | $354,236 | $308,387 | $181,668 |
| Non-Current Assets | |||||
| PPE Net | 632 | 1,341 | 2,197 | 2,813 | 3,195 |
| Intangibles | 6,174 | 7,028 | 7,883 | 4,658 | 0 |
| Other Non-Current Assets | 11,267 | 16,108 | 18,165 | 13,665 | 2,210 |
| TOTAL | $18,073 | $24,477 | $28,245 | $21,136 | $5,405 |
| Total Assets | $392,273 | $332,745 | $382,481 | $329,523 | $187,073 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,328 | 4,885 | 4,797 | 5,737 | 4,900 |
| Accrued Expenses | 62,658 | 48,262 | 32,894 | 30,084 | 12,559 |
| Other current liabilities | 37,704 | 0 | N/A | N/A | N/A |
| TOTAL | $115,517 | $55,203 | $39,809 | $43,427 | $17,994 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,827 | 1,286 | 1,434 | 7,000 | N/A |
| Other Non-Current Liabilities | 3,938 | 1,640 | 2,600 | 1,945 | 2,551 |
| TOTAL | $112,207 | $107,783 | $78,410 | $1,945 | $2,551 |
| Total Liabilities | $227,724 | $162,986 | $118,219 | $45,372 | $20,545 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,224 | 60,141 | 56,748 | 50,330 | 50,181 |
| Common Shares | 61 | 59 | 56 | 50 | 44 |
| Retained earnings | -1,155,338 | -894,736 | -710,058 | -528,939 | -459,327 |
| Other shareholders' equity | 142,781 | 134 | -92 | -1 | 49 |
| TOTAL | $164,549 | $169,759 | $264,262 | $284,151 | $166,528 |
| Total Liabilities And Equity | $392,273 | $332,745 | $382,481 | $329,523 | $187,073 |